5 results
Insight
GCR Life Sciences 2025 recap: Competition, innovation, and market dynamics
Article
United States: Pharmaceutical Antitrust 2025
Alert
DOJ Antitrust Division Announces Deferred Prosecution Agreements with Two Pharmaceutical Companies Containing “Extraordinary” Divestiture Remedy
Article
United States: Pharmaceutical Antitrust 2024
Article
Third Circuit: Pharmaceutical Cases